Tech Stock News
Saturday, March 18, 2023
Senseonics Holdings Inc (NYSE: SENS) today announced an additional demonstration of PROMISE Study facts assessing the next generation Eversense CGM System at the American Diabetes Association Simulated 81st Annual Technical Meetings. Data presented by Satish Garg MD The data assessing the security and correctness of the next generation Eversense system […]
Senseonics Holdings Inc (NYSEAMERICAN: SENS) stock breakout and trades at $3.07 (down 10.5%) on June 9, 2021. If it sustains this level, the stock can easily reach $5 and above. The stock gained 43% on June 4, 2021, because Senseonics posted impressive clinical results of its implantable CGM (continuous glucose […]
Senseonics Holdings Inc (NYSEAMERICAN: SENS) closed at $2.91 on Friday, surging 42% after announcing promising results from its clinical study of the CGM system. This medical technology company is focused primarily on creating continuous glucose monitoring (CGM) system or CGM, which is marketed as a one-of-its-kind, long-term and implantable system […]